164 related articles for article (PubMed ID: 10514442)
41. Genes, cloned cDNAs, and proteins of human trypsinogens and pancreatitis-associated cationic trypsinogen mutations.
Chen JM; Ferec C
Pancreas; 2000 Jul; 21(1):57-62. PubMed ID: 10881933
[TBL] [Abstract][Full Text] [Related]
42. Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y.
Szmola R; Sahin-Tóth M
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11227-32. PubMed ID: 17592142
[TBL] [Abstract][Full Text] [Related]
43. Mutations in exons 2 and 3 of the cationic trypsinogen gene in Japanese families with hereditary pancreatitis.
Nishimori I; Kamakura M; Fujikawa-Adachi K; Morita M; Onishi S; Yokoyama K; Makino I; Ishida H; Yamamoto M; Watanabe S; Ogawa M
Gut; 1999 Feb; 44(2):259-63. PubMed ID: 9895387
[TBL] [Abstract][Full Text] [Related]
44. Premature trypsin activation in hereditary pancreatitis.
Blackstone M
Gastroenterology; 1998 Sep; 115(3):796-9. PubMed ID: 9742004
[No Abstract] [Full Text] [Related]
45. Ostrich trypsinogen: purification, kinetic properties and characterization of the pancreatic enzyme.
Bodley MD; Naudé RJ; Oelofsen W; Pátthy A
Int J Biochem Cell Biol; 1995 Jul; 27(7):719-28. PubMed ID: 7648428
[TBL] [Abstract][Full Text] [Related]
46. Enteropeptidase, a type II transmembrane serine protease.
Zheng XL; Kitamoto Y; Sadler JE
Front Biosci (Elite Ed); 2009 Jun; 1(1):242-9. PubMed ID: 19482641
[TBL] [Abstract][Full Text] [Related]
47. Novel cationic trypsinogen (PRSS1) N29T and R122C mutations cause autosomal dominant hereditary pancreatitis.
Pfützer R; Myers E; Applebaum-Shapiro S; Finch R; Ellis I; Neoptolemos J; Kant JA; Whitcomb DC
Gut; 2002 Feb; 50(2):271-2. PubMed ID: 11788572
[TBL] [Abstract][Full Text] [Related]
48. Engineering mouse cationic trypsinogen for rapid and selective activation by cathepsin B.
Demcsák A; Geisz A; Sahin-Tóth M
Sci Rep; 2019 Jun; 9(1):9188. PubMed ID: 31235832
[TBL] [Abstract][Full Text] [Related]
49. Intra-acinar cell activation of trypsinogen during caerulein-induced pancreatitis in rats.
Hofbauer B; Saluja AK; Lerch MM; Bhagat L; Bhatia M; Lee HS; Frossard JL; Adler G; Steer ML
Am J Physiol; 1998 Aug; 275(2):G352-62. PubMed ID: 9688663
[TBL] [Abstract][Full Text] [Related]
50. Activating effect of the Ile-Val dipeptide on the catalytic properties of bovine trypsinogen.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
Biochim Biophys Acta; 1985 Nov; 832(1):1-6. PubMed ID: 4052434
[TBL] [Abstract][Full Text] [Related]
51. Biochemical characterization of recombinant Penaeus vannamei trypsinogen.
Guerrero-Olazarán M; Castillo-Galván M; Gallegos-López JA; Fuentes-Garibay JA; Viader-Salvadó JM
Comp Biochem Physiol B Biochem Mol Biol; 2019 Dec; 238():110337. PubMed ID: 31476362
[TBL] [Abstract][Full Text] [Related]
52. Discrimination of three mutational events that result in a disruption of the R122 primary autolysis site of the human cationic trypsinogen (PRSS1) by denaturing high performance liquid chromatography.
Le Maréchal C; Chen JM; Quéré I; Raguénès O; Férec C; Auroux J
BMC Genet; 2001; 2():19. PubMed ID: 11734061
[TBL] [Abstract][Full Text] [Related]
53. Mutational screening of patients with nonalcoholic chronic pancreatitis: identification of further trypsinogen variants.
Teich N; Bauer N; Mössner J; Keim V
Am J Gastroenterol; 2002 Feb; 97(2):341-6. PubMed ID: 11866271
[TBL] [Abstract][Full Text] [Related]
54. A preclinical model of chronic pancreatitis driven by trypsinogen autoactivation.
Geisz A; Sahin-Tóth M
Nat Commun; 2018 Nov; 9(1):5033. PubMed ID: 30487519
[TBL] [Abstract][Full Text] [Related]
55. Hereditary pancreatitis.
Charnley RM
World J Gastroenterol; 2003 Jan; 9(1):1-4. PubMed ID: 12508340
[TBL] [Abstract][Full Text] [Related]
56. Mutations of the cationic trypsinogen gene in hereditary and non-hereditary pancreatitis.
O'Reilly DA; Yang BM; Creighton JE; Demaine AG; Kingsnorth AN
Digestion; 2001; 64(1):54-60. PubMed ID: 11549837
[TBL] [Abstract][Full Text] [Related]
57. Mouse model of PRSS1 p.R122H-related hereditary pancreatitis highlights context-dependent effect of autolysis-site mutation.
Jancsó Z; Morales Granda NC; Demcsák A; Sahin-Tóth M
Pancreatology; 2023 Mar; 23(2):131-142. PubMed ID: 36797199
[TBL] [Abstract][Full Text] [Related]
58. Possible lysosomal activation of pancreatic zymogens. Activation of both human trypsinogens by cathepsin B and spontaneous acid. Activation of human trypsinogen 1.
Figarella C; Miszczuk-Jamska B; Barrett AJ
Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():293-8. PubMed ID: 3202969
[TBL] [Abstract][Full Text] [Related]
59. Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid.
Rinderknecht H; Renner IG; Abramson SB; Carmack C
Gastroenterology; 1984 Apr; 86(4):681-92. PubMed ID: 6698368
[TBL] [Abstract][Full Text] [Related]
60. Amino acid sequence of human tumor derived angiogenin.
Strydom DJ; Fett JW; Lobb RR; Alderman EM; Bethune JL; Riordan JF; Vallee BL
Biochemistry; 1985 Sep; 24(20):5486-94. PubMed ID: 2866794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
